Miro heads operations and strategy for Rare Disease Research (RDR), a growing independent site network for rare disease trials. In addition to conducting over 50 active rate disease clinical trials, RDR is solving other pressing problems in clinical research, Offering a full-featured cloud CTMS for sites (Davesa Health) and a research home health service for decentralized rare disease and pediatric trials (Gooseberry Research). He brings twenty years of experience in marketing and investment management and earned his Ph.D in molecular and cell biology from UC Berkeley.